View all IQVIA events


There is an impressive and growing array of Real World Data (RWD) sources available, and their use is being increasingly fueled by recent Real World Evidence (RWE) trends including the uptake of digital health, patient-generated data, and telemedicine within the current COVID-19 environment. Organizations are recognizing the benefits of incorporating real world data sources into their overall development plans as they see more and more instances in which RWD has contributed to regulatory approvals for rare diseases and informed prescribing decisions or innovative payment models.
Nathalie Horowicz-Mehler, PhD, MPH
Senior Principal, Head of Real World Evidence Strategy
IQVIA